RECENT ADVANCES IN PRECISION PHARMACOLOGY: NOVEL DRUG TARGETING STRATEGIES AND THEIR IMPACT ON PERSONALIZED THERAPY

Abstract

Precision pharmacology has emerged as a transformative approach in modern therapeutics, enabling individualized treatment based on genetic, molecular, environmental, and phenotypic characteristics of patients. Traditional pharmacotherapy often follows a generalized treatment paradigm that may lead to variable therapeutic outcomes, adverse drug reactions, and treatment resistance among individuals. The growing understanding of molecular biology, pharmacogenomics, bioinformatics, and advanced drug delivery systems has accelerated the development of precision pharmacology, which aims to optimize therapeutic efficacy and minimize toxicity. Recent advancements in novel drug targeting strategies, including ligand-mediated targeting, receptor-specific drug delivery, nanotechnology-based therapeutics, antibody-drug conjugates, RNA-based therapeutics, and gene-editing technologies, have significantly improved disease management and patient outcomes. Artificial intelligence and machine learning technologies are further enhancing drug discovery, biomarker identification, and personalized therapeutic decision-making. Precision pharmacology has shown substantial clinical utility in oncology, psychiatry, cardiovascular medicine, neurology, and infectious diseases by facilitating individualized therapeutic regimens tailored to genetic and molecular profiles. Despite promising advancements, challenges such as high treatment costs, limited accessibility, ethical concerns, regulatory complexities, and insufficient genomic infrastructure continue to restrict widespread implementation. Future developments in precision pharmacology are expected to integrate advanced computational technologies, real-world clinical evidence, and molecular diagnostics to establish more effective patient-centered healthcare systems. This review comprehensively discusses recent advances in precision pharmacology, novel drug targeting strategies, clinical applications, challenges, and future implications in personalized therapy while emphasizing the transformative role of precision medicine in improving therapeutic outcomes and healthcare sustainability.